Back to Journals » Clinical Ophthalmology » Volume 17

Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study

Total article views   HTML views PDF downloads Totals
4,646 Dovepress* 4,289+ 178 4,467
PubMed Central* 357 101 458
Totals 4,646 279 4,925
*Since 4 March 2023
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar